Podcasts

Targeting STAT3 in Tumors with Oligo-PROTAC with Dr. Marcin Kortylewski

Listen to this episode of The Molecular Therapy Podcast - July 09, 2024

If you enjoy today’s conversation, you’ll also enjoy the upcoming ASGCT Policy Summit in Washington, DC, September 23-24. 

Join ASGCT and the Molecular Therapy family of journals for a conversation between Drs. Paloma Giangrande and Marcin Kortylewski. They discuss a recent article published in Molecular Therapy Nucleic Acids by Dr. Kortylewski and colleagues titled "Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3."

Follow the ASGCT Podcast Network wherever you listen to podcasts!

          YouTUbe.png

If you enjoy today’s conversation, you’ll also enjoy the upcoming ASGCT Policy Summit in Washington, DC, September 23-24. 

This can't-miss event brings together policymakers and gene and cell therapy experts, including FDA leaders Julie Tierney and Dr. Nicole Verdun, to discuss the latest policies impacting this rapidly evolving field. 

Register now for invaluable insights on navigating the regulatory landscape. 

In This Episode:

Dr. Paloma Giangrande
Editor-in-Chief of Molecular Therapy Nucleic Acids and Chief Technology Officer at Eleven Therapeutics

Dr. Marcin Kortylewski
Professor, Department of Immuno-Oncology at City of Hope

'Electric Dreams' by Scott Buckley - released under CC-BY 4.0.
www.scottbuckley.com.au

Related Articles

Podcasts

CRISPR and Beyond with Vertex CSO David Altshuler, MD, PhD—ASGCT's The Issue

July 16, 2024
Molecular Therapy

AAV Capsid Production with Drs. Mario Mietzsch and Robert McKenna

Molecular Therapy Podcast - June 18, 2024
Podcasts

Gene Insertion Tech with SalioGen CEO Jason Cole

ASGCT Podcast Network - June 11, 2024
Molecular Therapy

A New Vision for MTMCD with EiC Dr. Mohamed Abou-el-Enein

ASGCT Podcast Network - June 04, 2024